93 related articles for article (PubMed ID: 36425957)
1. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.
Oldridge DA; Wood AC; Weichert-Leahey N; Crimmins I; Sussman R; Winter C; McDaniel LD; Diamond M; Hart LS; Zhu S; Durbin AD; Abraham BJ; Anders L; Tian L; Zhang S; Wei JS; Khan J; Bramlett K; Rahman N; Capasso M; Iolascon A; Gerhard DS; Guidry Auvil JM; Young RA; Hakonarson H; Diskin SJ; Look AT; Maris JM
Nature; 2015 Dec; 528(7582):418-21. PubMed ID: 26560027
[TBL] [Abstract][Full Text] [Related]
2. A Focus on Regulatory Networks Linking MicroRNAs, Transcription Factors and Target Genes in Neuroblastoma.
Perri P; Ponzoni M; Corrias MV; Ceccherini I; Candiani S; Bachetti T
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771690
[TBL] [Abstract][Full Text] [Related]
3. Plasticity in Neuroblastoma Cell Identity Defines a Noradrenergic-to-Mesenchymal Transition (NMT).
Gautier M; Thirant C; Delattre O; Janoueix-Lerosey I
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34200747
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization.
Clavero E; Sanchez-Maldonado JM; Macauda A; Ter Horst R; Sampaio-Marques B; Jurczyszyn A; Clay-Gilmour A; Stein A; Hildebrandt MAT; Weinhold N; Buda G; García-Sanz R; Tomczak W; Vogel U; Jerez A; Zawirska D; Wątek M; Hofmann JN; Landi S; Spinelli JJ; Butrym A; Kumar A; Martínez-López J; Galimberti S; Sarasquete ME; Subocz E; Iskierka-Jażdżewska E; Giles GG; Rybicka-Ramos M; Kruszewski M; Abildgaard N; Verdejo FG; Sánchez Rovira P; da Silva Filho MI; Kadar K; Razny M; Cozen W; Pelosini M; Jurado M; Bhatti P; Dudzinski M; Druzd-Sitek A; Orciuolo E; Li Y; Norman AD; Zaucha JM; Reis RM; Markiewicz M; Rodríguez Sevilla JJ; Andersen V; Jamroziak K; Hemminki K; Berndt SI; Rajkumar V; Mazur G; Kumar SK; Ludovico P; Nagler A; Chanock SJ; Dumontet C; Machiela MJ; Varkonyi J; Camp NJ; Ziv E; Vangsted AJ; Brown EE; Campa D; Vachon CM; Netea MG; Canzian F; Försti A; Sainz J
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239846
[TBL] [Abstract][Full Text] [Related]
5.
Giardoglou P; Deloukas P; Dedoussis G; Beis D
Cells; 2023 Aug; 12(15):. PubMed ID: 37566073
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the developmental origin of neuroblastoma: an overview.
Ponzoni M; Bachetti T; Corrias MV; Brignole C; Pastorino F; Calarco E; Bensa V; Giusto E; Ceccherini I; Perri P
J Exp Clin Cancer Res; 2022 Mar; 41(1):92. PubMed ID: 35277192
[TBL] [Abstract][Full Text] [Related]
7. LMO1 polymorphisms and the risk of neuroblastoma: Assessment of meta-analysis of case-control studies.
Hashemi M; Sarabandi S; Karami S; Śmieja J; Moazeni-Roodi A; Ghavami S; Łos MJ
J Cell Mol Med; 2020 Jan; 24(2):1160-1168. PubMed ID: 31830377
[TBL] [Abstract][Full Text] [Related]
8.
Formicola D; Lasorsa VA; Cantalupo S; Testori A; Cardinale A; Avitabile M; Diskin S; Iolascon A; Capasso M
HGG Adv; 2023 Jan; 4(1):100158. PubMed ID: 36425957
[TBL] [Abstract][Full Text] [Related]
9. Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene.
Avitabile M; Succoio M; Testori A; Cardinale A; Vaksman Z; Lasorsa VA; Cantalupo S; Esposito M; Cimmino F; Montella A; Formicola D; Koster J; Andreotti V; Ghiorzo P; Romano MF; Staibano S; Scalvenzi M; Ayala F; Hakonarson H; Corrias MV; Devoto M; Law MH; Iles MM; Brown K; Diskin S; Zambrano N; Iolascon A; Capasso M
Carcinogenesis; 2020 May; 41(3):284-295. PubMed ID: 31605138
[TBL] [Abstract][Full Text] [Related]
10. Exploring Shared Susceptibility between Two Neural Crest Cells Originating Conditions: Neuroblastoma and Congenital Heart Disease.
Testori A; Lasorsa VA; Cimmino F; Cantalupo S; Cardinale A; Avitabile M; Limongelli G; Russo MG; Diskin S; Maris J; Devoto M; Keavney B; Cordell HJ; Iolascon A; Capasso M
Genes (Basel); 2019 Aug; 10(9):. PubMed ID: 31480262
[TBL] [Abstract][Full Text] [Related]
11. PHOX2B mutations and genetic predisposition to neuroblastoma.
Perri P; Bachetti T; Longo L; Matera I; Seri M; Tonini GP; Ceccherini I
Oncogene; 2005 Apr; 24(18):3050-3. PubMed ID: 15735672
[TBL] [Abstract][Full Text] [Related]
12. Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility.
Capasso M; Diskin SJ; Totaro F; Longo L; De Mariano M; Russo R; Cimmino F; Hakonarson H; Tonini GP; Devoto M; Maris JM; Iolascon A
Carcinogenesis; 2013 Mar; 34(3):605-11. PubMed ID: 23222812
[TBL] [Abstract][Full Text] [Related]
13. PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma.
Bachetti T; Di Paolo D; Di Lascio S; Mirisola V; Brignole C; Bellotti M; Caffa I; Ferraris C; Fiore M; Fornasari D; Chiarle R; Borghini S; Pfeffer U; Ponzoni M; Ceccherini I; Perri P
PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957039
[TBL] [Abstract][Full Text] [Related]
14. Somatic Mutations Enriched in Cis-Regulatory Elements Affect Genes Involved in Embryonic Development and Immune System Response in Neuroblastoma.
Lasorsa VA; Montella A; Cantalupo S; Tirelli M; de Torres C; Aveic S; Tonini GP; Iolascon A; Capasso M
Cancer Res; 2022 Apr; 82(7):1193-1207. PubMed ID: 35101866
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
